Issue
Alert me when new journal issues are available via or via
Aims & scope/editorial board page iii Full-Text PDF (45 KB)
Why is clinical progress in acute myelogenous leukemia so slow? Jacob M. Rowe pages 1-3 Full Text | Full-Text PDF (148 KB)
Apoptosis in leukemia: From molecular pathways to targeted therapies Aaron D. Schimmer pages 5-11 Abstract | Full Text | Full-Text PDF (140 KB)
Can FLT3 inhibitors overcome resistance in AML? Winnie F. Tam, D. Gary Gilliland pages 13-20 Abstract | Full Text | Full-Text PDF (412 KB)
Has gene expression profiling improved diagnosis, classification, and outcome prediction in AML? Cheryl L. Willman pages 21-28 Abstract | Full Text | Full-Text PDF (420 KB)
New approaches in acute myeloid leukemia William Blum, Guido Marcucci pages 29-41 Abstract | Full Text | Full-Text PDF (161 KB)
Is it important to decipher the heterogeneity of “normal karyotype AML”? Stephen D. Nimer pages 43-52 Abstract | Full Text | Full-Text PDF (160 KB)
Consolidation therapy: What should be the standard of care? Jacob M. Rowe pages 53-60 Abstract | Full Text | Full-Text PDF (279 KB)
Older adults: Should the paradigm shift from standard therapy? Elihu H. Estey pages 61-66 Abstract | Full Text | Full-Text PDF (159 KB)
Hematopoietic cell transplantation for patients with myelodysplastic syndromes (MDS): When, how and for whom? Mario Marcondes, H. Joachim Deeg pages 67-77 Abstract | Full Text | Full-Text PDF (303 KB)
Should all unrelated donors for transplantation be matched? Daniel Weisdorf pages 79-83 Abstract | Full Text | Full-Text PDF (99 KB)
Incorporating hematopoietic cell transplantation (HCT) into the management of adults aged under 60 years with acute myeloid leukemia (AML) Frederick R. Appelbaum pages 85-92 Abstract | Full Text | Full-Text PDF (158 KB)
Are there effective new strategies for the treatment of acute and chronic GvHD? Nelson J. Chao pages 93-98 Abstract | Full Text | Full-Text PDF (191 KB)
Index pages I-II Full-Text PDF (62 KB)
Copyright © 2010 Elsevier, Inc. All rights reserved | Privacy Policy | Terms & Conditions | Feedback | About Us | Help | Contact Us | The content on this site is intended for health professionals.
